About Event
The Ultimate Industry Forum for Developers of GLP-1-Based Therapeutics Across Different Indications
The GLP-1-Based Therapeutics Summit is the exclusive gateway to gain insights into cutting-edge therapies demonstrating the vast potential to expand into new indications as well as extensive commercial value in obesity and diabetes.
If you are looking to differentiate your GLP-1 products, stand out in the market, or discover the newest innovations in improving tolerability, efficacy, and durability of GLP-1s, there has never been a more appropriate time to unite and navigate this rapidly evolving space!
Agenda Highlights
Optimizing the Efficacy of GLP-1-Based Therapeutics
Hear the newest innovations raising the benchmark for more successful weight loss with Diasome Pharmaceuticals and BioAge Labs
Enhancing the Tolerability of GLP-1 Receptor Agonists
Assess advanced modes of delivery and combination therapy to improve the quality of life for patients and increase adherence of treatment with Novo Nordisk and i2o Therapeutics
Unraveling Exciting Opportunities to Apply GLP-1 Receptor Agonists Across a Wide Range of Indications
Including cardiovascular, renal, obstructive sleep apnea, MASH, and neurodegenerative diseases with Eli Lily, D&D Pharmatech, and Altimmune
Planning for Potential Regulatory Challenges
Assess the impact of the Inflation Reduction Act and safety concerns on GLP-1s to address bottlenecks early with Pfizer and Roche
Enhancing the Durability of GLP-1-Based Therapies
Explore strategies for improving the durability of GLP-1-based therapies, and understand the effect durability has on adherence and maintenance of weight loss with Carmot Therapeutics
Developing a Robust Commercial Strategy
Differentiate your GLP-1 products from your competitors, to effectively target specific patient segments with Altimmune and Regor Therapeutics
Download the Full Agenda for More Information on:
-
- 19+ GLP-1 Industry Expert Speakers
-
- 8+ Hours of Industry Networking
-
- & Much More!
